Sector: University & Research Institutions

Latest content

New Brazilian biotech patent examination guidelines a “missed opportunity”

While boosting transparency, the many difficulties faced by life sciences innovators when applying for protection in the country are not addressed

14 January 2021

Newly-passed Orange Book law leaves the big questions unanswered

Clearing up remaining uncertainties over FDA patent listings will be the subject of intense debate in the US over coming months

12 January 2021

South Korea's Intellectual Discovery is in the process of becoming a big league, mainstream NPE

A year after a major capital infusion and a change of leadership, the firm has notched some notable settlements in the US and laid the groundwork for new assertion campaigns

08 January 2021

Three life sciences trade secrets and data strategy lessons

As non-patent assets become increasingly important, pharma and biotech innovators must adapt their IP strategies.

22 December 2020

Five key insights into 2020’s drug royalty transactions

It has been a year of creative and flexible deal-making with many life sciences entities taking advantage of the revenues this kind of IP monetisation can deliver

16 December 2020

East Asian giants leave their stamp on the IP market

IAM reveals the Asia IP Elite members for 2020 from two dynamic high-tech jurisdictions: South Korea and Taiwan

15 December 2020

The Asia IP Elite – a shared commitment to excellence across very different markets

IAM reveals the top in-house IP teams from India, Southeast Asia and Australasia

14 December 2020

Australian vaccine patent ruling shows tough new support requirements for life sciences innovators

Wyeth’s dispute with MSD underscores move towards stricter, UK-style disclosure obligations for IP rights

08 December 2020

New patent politics put US public-private partnerships under threat, says BIO’s IP chief

In an exclusive interview, Hans Sauer talks of concerns over a shift in federal strategy and argues that government research funding should not be seen as a commercial investment

03 December 2020

PARC goes on patent offensive against Facebook, Snap and Twitter

Very rare assertion campaign by the Xerox subsidiary sees three suits filed in US district court against social media giants

30 November 2020

Get unlimited access to all IAM content